Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

292 та иш

Иш: CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment

  1. Stem cells and common biomaterials in dentistry: a review study

    Seyed Ali Mosaddad, Boshra Rasoolzade, Reza Abdollahi Namanloo +2

    Шарҳ мақола20228 иқтибос
    ABI

  2. Pan-cancer analysis and experiments with cell lines reveal that the slightly elevated expression of DLGAP5 is involved in clear cell renal cell carcinoma progression

    Yun Feng, Fang Li, Jing Yan +15

    Мақола20215 иқтибос
    ABI

  3. Global stabilization of the full attraction-repulsion Keller-Segel system

    Hai‐Yang Jin, Zhi‐An Wang

    Мақола20193 иқтибос
    ABI

  4. Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis

    Navid Shomali, Behzad Baradaran, Amin Daei Sorkhabi +12

    Мақола20223 иқтибос
    ABI

  5. VEGF as a Key Mediator of Angiogenesis in Cancer

    Peter Carmeliet

    Шарҳ мақола20053 иқтибос
    ABI

  6. Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells

    M.-s. Jung, Jin Kyung Rho, Y-M Kim +7

    Мақола20122 иқтибос
    ABI

  7. Tempol effect on epithelial-mesenchymal transition induced by hyperglycemia

    Mohammad Jafari, Farahnaz Dadras, Hamid Reza Ghadimipour +2

    Мақола20162 иқтибос
    ABI

  8. Epithelial and endothelial mesenchymal transition and their role in diabetic kidney disease

    Farahnaz Dadras, Vida Sheikh, Farhad Khoshjou

    Мақола20172 иқтибос
    ABI

  9. RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer

    Xinbing Sui, Ruonan Zhang, Shuiping Liu +8

    Мақола20182 иқтибос
    ABI

  10. Factors associated with delayed diagnosis of breast cancer; a study in North-West of Iran

    Nasrin Fouladi, Maedeh Barahman, Firouz Amani +2

    Мақола20192 иқтибос
    ABI

  11. The emerging molecular mechanism of m6A modulators in tumorigenesis and cancer progression

    Shuiping Liu, Qiujie Li, Ke Chen +7

    Шарҳ мақола20202 иқтибос
    ABI

  12. <p>Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review</p>

    Jie Li, Jiaqian Zhao, Tiantian Tan +7

    Шарҳ мақола20202 иқтибос
    ABI

  13. Efficient isolation and identification of primary endothelial cells from bovine aorta by collagenase P

    Faezeh Seif, Alireza Kheirollah, Hossein Babaahmadi‐Rezaei

    Мақола20202 иқтибос
    ABI

  14. Relation between Immune cell response and stemness genes expression in breast cancer; A new approach in NANOG gene and Let7-a expression in breast cancer cell lines

    Zeynab Aliyari-Serej, Ayyub Ebrahımı, Tohid Kazemi +4

    Мақола20202 иқтибос
    ABI

  15. Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective

    Yuan Gao, Hang Zhang, Frédéric Lirussi +3

    Шарҳ мақола20202 иқтибос
    ABI

  16. Small molecule DNA-PK inhibitors as potential cancer therapy: a patent review (2010–present)

    Suwen Hu, Zi Hui, Frédéric Lirussi +3

    Шарҳ мақола20202 иқтибос
    ABI

  17. MgFe‐LDH Nanoparticles: A Promising Leukemia Inhibitory Factor Replacement for Self‐Renewal and Pluripotency Maintenance in Cultured Mouse Embryonic Stem Cells

    Xiaolie He, Yanjing Zhu, Li Yang +6

    Мақола20212 иқтибос
    ABI

  18. Prognostic implication of PD-L1 expression and associated tumor infiltrating lymphocytes in metastatic breast cancer

    Mohamed M Darwish, Atef Youssef Riad, Dina Salem +3

    Мақола20212 иқтибос
    ABI

  19. Lung cancer risk and the inhibitors of angiotensin converting enzyme; an updated review on recent evidence

    Maryam Khosravian, Mahnaz Momenzadeh, Farzad Koosha +2

    Мақола20212 иқтибос
    ABI

  20. The regulatory role of autophagy-related miRNAs in lung cancer drug resistance

    Mahshid Shahverdi, Khalil Hajiasgharzadeh, Amin Daei Sorkhabi +9

    Шарҳ мақола20222 иқтибос
    ABI

  21. RETRACTED: Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies

    Navid Shomali, Marwah Suliman Maashi, Behzad Baradaran +7

    Шарҳ мақола20222 иқтибос
    ABI

  22. The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme

    Amin Daei Sorkhabi, Aila Sarkesh, Hossein Saeedi +5

    Шарҳ мақола20222 иқтибос
    ABI

  23. Cancer combination therapies by silencing of CTLA‐4, PD‐L1, and TIM3 in osteosarcoma

    Amin Daei Sorkhabi, Aila Sarkesh, Ali Fotouhi +2

    Мақола20222 иқтибос
    ABI

  24. Evaluation of the urine mRNA-PCA3 expression level in prostate patients; comparison between benign prostatic hyperplasia and cancer

    Amid Yazdani, Farshad Namdari, Sattar Gorgani‐Firuzjaee +1

    Мақола20222 иқтибос
    ABI

  25. Survival rates and prognostic factors of thyroid cancer: A retrospective cohort study

    Ali Amri, Ali Reza Soltanian, Shiva Borzouei

    Мақола20222 иқтибос
    ABI